Overview
This trail is for patients with mild cognitive impairment (MCI) who are receiving a transcatheter aortic valve replacement (TAVR). We will assess changes in neurocognition following TAVR with the 5 minute Montreal Cognitive Assessment (mini MoCA) when comparing pre procedure with post procedure assessments.
Description
Patients with mild cognitive impairment who are being treated with a TAVR can choose to take part in this trial. This trial will prospectively enroll patients at 4 Baylor Scott & White facilities. 80 patients will be enrolled between all sites. The mini MoCA will be conducted at the following time points: pre TAVR, 30 days post TAVR, and 6 months post TAVR. All other data will be collected from patient charts and are considered standard part of their care.
Eligibility
Inclusion Criteria:
- Age 18 years or older
- Undergoing a TAVR procedure
- Possible MCI as determined by procedures already used in the TAVR clinics, including 1
of the 4:
- MMSE < 27
- History of MCI, dementia, or stroke (CVA or TIA)
- History of prescription treatment for MCI
- Discretion of the investigator, physician, or clinic staff
- Scores 25 or less on the mini MoCA exam
Exclusion Criteria:
- In another research study that doesn't allow dual enrolment, or dual enrolment has not been granted.